During the past decade, Northern Ireland Cancer Centre conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Northern Ireland Cancer Centre" #1 collaborator was "NHS Greater Glasgow and Clyde" with 2 trials as a collaborator, "Cancer Research UK" with 1 trials as a collaborator and "University of Glasgow" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Northern Ireland Cancer Centre" are "Neoplasms Pancreatic" (2 trials). Many other conditions were trialed in "Northern Ireland Cancer Centre" in a lesser frequency.

Most popular intervention types in "Northern Ireland Cancer Centre" are "Drug" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "FOLFOX-A" (1 trials), "G-CSF" (1 trials), "Gemcitabe and Abraxane" (1 trials) and "Patients with suspected or confirmed pancreatic cancer will be be asked to provide biopsy material for molecular profiling" (1 trials). Other intervention names were less common.

The vast majority of trials in "Northern Ireland Cancer Centre" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Northern Ireland Cancer Centre". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Northern Ireland Cancer Centre, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Northern Ireland Cancer Centre, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".